PDS Biotechnology
PDSB
39 hedge funds and large institutions have $158M invested in PDS Biotechnology in 2015 Q4 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.8M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
+$37.8M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$37M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$14.2M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$11.4M |
Top Sellers
PDSB Hedge Fund Activity: Q4 2015 in Review
39 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q4 2015, worth a combined $158M.
Buyers outnumbered sellers: 39 funds opened new PDSB positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $46.8M.
- 39 institutional investors held PDS Biotechnology (PDSB) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $158M of PDS Biotechnology stock for Q4 2015.
- 39 funds opened new PDS Biotechnology positions in Q4 2015 and 0 closed out, a net change of +39 holders.
- The largest PDS Biotechnology buyer in Q4 2015 was Fidelity Investments, an estimated $46.8M added.
Based on aggregated 13F filings for Q4 2015.